When What You See Is Not Always What You Get: Raising the Bar of Evidence for New Diagnostic Imaging Modalities.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 32847699.
- Also identified by DOI 10.1016/j.eururo.2020.07.029.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Even though prostate-specific membrane antigen (PSMA)-positron emission tomography (PET)-computed tomography (CT) is more accurate than conventional imaging in prostate cancer patients, its impact on patient-relevant outcomes is unknown. We argue that more evidence is required before using PSMA-PET-CT as the standard of care for staging.
Medical subject headings
- Positron Emission Tomography Computed Tomography
- Prostatic Neoplasms